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Abstract
We evaluated glutathione transferase (GST) activities
and the levels of glutathionylated hemoglobin in the
RBC of 42 workers exposed to 1,3-butadiene in a
petrochemical plant, using 43 workers not exposed to
1,3-butadiene and 82 foresters as internal and external
controls, respectively. Median 1,3-butadiene exposure
levels were 1.5, 0.4, and 0.1 Mg/m3 in 1,3-butadiene-
exposed workers, in workers not directly exposed to
1,3-butadiene, and in foresters, respectively. In addi-
tion, we determined in the peripheral blood lympho-
cytes of the same individuals the presence of GST
polymorphic genes GSTT1 and GSTM1 and the
distribution of GSTP1 allelic variants. Comparing
the mean values observed in petrochemical workers
with those of control foresters, we found a marked
decrease of GST enzymatic activity and a significant
increase of glutathionylated hemoglobin in the petro-
chemical workers. A weak but significant negative
correlation was found between levels of 1,3-butadiene
exposure and GST activity, whereas a positive
correlation was found between 1,3-butadiene exposure
and glutathionylated hemoglobin. A negative correla-
tion was also observed between GST activity and
glutathionylated hemoglobin. No influence of con-
founders was observed. Using a multiple linear
regression model, up to 50.6% and 41.9% of the
variability observed in glutathionylated hemoglobin
and GST activity, respectively, were explained by 1,3-
butadiene exposure, working setting, and GSTT1
genotype. These results indicate that occupational
exposure to 1,3-butadiene induces an oxidative stress
that impairs the GST balance in RBC, and suggest
that GST activity and glutathionylated hemoglobin
could be recommended as promising biomarkers of
effect in petrochemical workers. (Cancer Epidemiol
Biomarkers Prev 2008;17(11):3004–12)
Introduction
Exposure to 1,3-butadiene, a common solvent in the
chemical production of resin, rubber, and latex, is one of
the major concerns among the toxic compounds encoun-
tered in the environment (pollution) or in the chemical
industry. Recently the IARC classified 1,3-butadiene as a
‘‘carcinogen to humans’’ (group 1) on the basis of
sufficient evidence of an increased risk of leukemia in
humans (1). Most 1,3-butadiene reactive metabolites
(mono- and di-epoxybutene) or their close metabolite
(3,4-epoxy-1,2-butanediol) are able to form adducts with
proteins (such as hemoglobin) and DNA, giving rise to
genotoxic effects and eventually to a carcinogenesis
process. These macromolecular adducts (biomarkers of
exposure) and chromosome aberrations, micronuclei,
and other biomarkers of effects have been tentatively
associated with the genetic polymorphism of the cyto-
chrome P-450 and glutathione transferases (2).
The glutathione transferases (GST; EC 2.5.1.18) are
detoxifying enzymes that catalyze a nucleophilic attack
by reduced glutathione (GSH) on nonpolar compounds
that contain an electrophilic carbon, nitrogen, or sulfur
atom. Their substrates include halogen-nitrobenzenes,
arene oxides, quinones, epoxides, and a,h-unsaturated
carbonyls. Mammalian cytosolic GSTs are all dimeric
enzymes. Based on amino acid sequence similarities,
seven classes of cytosolic GSTs are recognized in
mammalian species, designated Alpha, Mu, Pi, Sigma,
Theta, Omega, and Zeta (3). Early studies reported that
the GSTM1 and GSTT1 genes display a null allele in
about 50% and 20% of the Caucasian population,
respectively (4, 5), whereas GSTP1 exhibit allelic variants
that encode enzymes with reduced catalytic activity (6).
Recently, more cytosolic polymorphic enzymes have
been identified (such as GST O1-1 and GST O2-2) but
very little is known about them (3).
The hypothesis that combinations of different poly-
morphisms in class Mu, Pi, and Theta GSTs and/or
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interindividual variability of GST expression may con-
tribute to the toxic response to an environmental
contaminant has been considered by many researchers
(7). There is no clear conclusion about the effect
(resulting in either protection or greater toxicity) exerted
in humans by these polymorphic enzymes. Recent
studies on knockout of mouse GST genes of different
classes indicate that disruption of a single gene up-
regulates, as a compensatory response, the antioxidant
responsive element–gene battery which includes differ-
ent GSTs and other antioxidant enzymes (3). Therefore,
future studies on the consequences of GST polymor-
phism on environment-related diseases should consider
the effect of different genes that are part of this
coordinated defense system.
In recent years, due to the well-known toxic effects of
1,3-butadiene, its concentration in the work environment
has been reduced in industrialized countries to levels
rarely exceeding the occupational limit values issued by
agencies dealing with hygiene and safety at work (8, 9).
In some working environments, 1,3-butadiene concen-
trations are comparable with those found in the general
urban environment, arising in this case from traffic
emissions (10, 11). This explains, at least in part, why it is
difficult to find a significant association between genetic
polymorphism and biomarkers of exposure/effect
in such workers (12, 13). Such low-level exposures,
however, lasting for a long time should also be
considered for their potential biological effects. In this
regard, we have evaluated the effects of exposure to low
doses of 1,3-butadiene on the enzymatic activity of
human GSTs in the RBC of petrochemical workers
occupationally exposed to this toxic compound, in
comparison with foresters as external controls. Because
butadiene epoxide could be a putative substrate of GST
T1-1 (3), we investigated the genetic polymorphism of
this class along with the other most studied cytosolic
classes (GST P1-1 and GST M1-1). In addition, the
glutathionylated hemoglobin has been determined in
the same samples by using a proteomic approach. The
results suggest that exposure to low doses of 1,3-
butadiene may induce oxidative stress and impairment
of antioxidant and detoxificant defense systems.
Materials and Methods
Subjects Under Study. Forty-two subjects working in
the production departments of a technologically ad-
vanced petrochemical plant were designated as occupa-
tionally exposed workers. They were involved in the
synthesis of 1,3-butadiene monomer and in its use to
produce various polymers: 1,3-butadiene-styrene rubber,
cis-polybutadiene rubber, styrene-butadiene latex, and
polybutadiene latex. Exposure to 1,3-butadiene was
involved in all these activities (from these production
activities they were all exposed to 1,3-butadiene), but
coexposure to other chemicals such as styrene, hexane,
cyclohexane, and a mixture of olefins, was also possible.
While on duty, the workers in the production work-
shops, except for regular sampling and circuit inspection
(once every hour), remained in control centers and
controlled the plant through video terminals. These
subjects are named hereafter as 1,3-butadiene-exposed
workers. Forty-three other subjects working in the same
plant, without direct involvement in 1,3-butadiene
production and use, were selected from the administra-
tive department, maintenance, and other production
units. These subjects are named hereafter as workers not
exposed to 1,3-butadiene (internal controls). Finally, 82
subjects working as foresters in a rural area of Northern
Italy were selected as external controls. The three groups
were matched for cigarette consumption. The following
inclusion criteria were adopted: male gender, Caucasian
race, working in the present job for at least 1 y, and healthy
status as evaluated by occupational health physicians on
the basis of the subject’s personal records. At the
beginning of the study all workers received information
about the aim of the research, and a written informed
consent was obtained from each of them.
Sampling. Personal exposure to airborne 1,3-butadiene
was assessed by collecting air samples during the work
shift (8 h). For 1,3-butadiene-exposed workers, the
assessment was repeated 3 to 4  over a period of 6 wk.
For workers not exposed to 1,3-butadiene (internal
controls), personal exposure to 1,3-butadienewas assessed
once. Finally, for the foresters acting as external controls,
personal exposure was assessed only on a subgroup of 24
subjects. The procedures used for personal sampling of
airborne 1,3-butadiene were as previously described (8).
On the last 1,3-butadiene sampling day for 1,3-butadiene-
exposed workers, or on the same day of air sampling for
the other subjects, blood samples were collected at the
beginning of the shift. From each subject, two venous
blood samples were collected in 5mL vials: one containing
heparin was used to evaluate GST enzymatic activity,
the other, containing EDTA, was utilized for genotyping
studies. Samples were blind-coded and delivered to the
laboratories for analysis. Both samples were stored at
80jC until use. After sampling, each subject was
interviewed by an occupational health physician and a
questionnaire was completed on lifestyle, smoking habits,
medical history, and occupational activities.
Airborne 1,3-Butadiene Levels. Airborne 1,3-butadi-
ene was measured within 2 wk from sample collection, in
order to ensure sample stability. The 1,3-butadiene was
thermally desorbed from the sampling tube and injected
into a gas chromatograph equipped with a Al2O3/KCl
HP Plot column (0.53 mm internal diameter, 60 mm
length, Agilent), and analyzed by a flame ionization
detector (GC 8000 Fison) according to a published
procedure (Health and Safety Executive , 1992) with some
modifications. The detection limit for airborne 1,3-
butadiene was 0.1 Ag/m3.
Chemicals. GSH, CDNB, and EPNP were from Sigma.
The MagNA Pure LC DNA Isolation Kit and Light-
Cycler DNA Master Hybridization Probes Kit were from
Roche Diagnostics.
Genotypes. Genomic DNA was purified from 200 AL
of whole human blood using the MagNA Pure LC DNA
Isolation Kit (Roche Diagnostics) in an automated
extractor from the kit’s manufacturer, MagNA Pure LC.
DNA was quantified spectrophotometrically at 260 nm
and stored at 4jC.
GST P1-1 Genotyping through PCR and Fluores-
cence Resonance Energy Transfer Using Light-Cycler.
Analyses of the GST polymorphisms resulting in a Ile to
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Val substitution at residue 104 in exon 5 and Ala to Val
substitution at residue 113 in exon 6 were done by Real-
time PCR on a Light-Cycler instrument (Roche Diagnos-
tics) using hybridization probes in combination with
the Light-Cycler DNA Master Hybridization Probes Kit
(Roche Diagnostics). The exon 5 PCR primers and
hybridization probes were synthesized according to
Harries et al. (14). The exon 6 PCR primers and
hybridization probes were synthesized according to
Ballerini et al. (15). The PCR conditions and the cycling
program for the exon 5 were essentially those described
by Ko et al. (16), whereas the cycling program for the
exon 6 and the conditions for measuring the fluorescence
were as previously reported (15).
Genetic Polymorphism Analysis of GSTM1 and
GSTT1 Genes. The genetic polymorphism analysis for
the GSTM1 and the GSTT1 genes was determined
simultaneously in a single assay using a multiplex PCR
technique, with the amplification of the GSTM1 and
GSTT1 genes from genomic DNA, and using h-globin
gene as internal control. The conditions used were as
described elsewhere (17) with slight modifications. The
GSTM1 and GSTT1 PCR primers were modified accord-
ing to Bell et al. (18) and Pemble et al. (5), respectively.
The h-globin primers were fw 5¶-GAAGAGCCA-
AGGACAGGTAC-3¶ and h-globin rev 5¶-CAACTT-
CATCCACGTTCACC-3¶. The PCR products from
coamplification of the GSTT1, GSTM1, and h-globin
genes were then resolved on a 2.5% agarose gel.
Enzymatic Assays. For assaying GST activity in
erythrocytes, the cells were sedimented at 400 g for
10 min and the supernatant (plasma) was discarded.
The erythrocytes were washed twice with 0.9% NaCl
solution, and the packed cells were resuspended in an
equal volume of 20 mmol/L phosphate buffer containing
2mmol/L EDTA. The erythrocytes were lysed by freezing
and thawing thrice and then centrifuged at 11,000 rpm
for 20 min. The hemoglobin concentration was deter-
mined with a Sysmex SF-3000 hematological analyzer
(Sysmex Corporation).
GST activity was assayed with two different substrates
(CDNB and EPNP) in order to distinguish between GST
P1-1 and GST T1-1 present in the RBC. CDNB is a general
substrate for most soluble GSTs, but it is not recognized as
a substrate by GST T1-1. This latter enzyme uses EPNP,
which is amore specific substrate for this class, although it
is used also by other classes such as GST P1-1 (3). The
activity of GST P1-1 was determined spectrophotometri-
cally at 37jC in 1 mL (final volume) of 0.1 mol/L
phosphate buffer (pH 6.5) containing 1 mmol/L GSH
and 1 mmol/L CDNB, as cosubstrate. The reaction was
monitored by following the product formation for 1min at
340 nm, e = 9.6 (mmol/L)-1 cm-1 (19). The activity of GST
T1-1 was determined spectrophotometrically at 37jC, in
0.5 cm light path cuvettes and 0.5 mL (final volume) of
0.1mol/L phosphate buffer (pH 6.5) containing 5mmol/L
GSH and 0.5 mmol/L EPNP as cosubstrate. The reaction
was monitored by following the product formation for
5 min at 360 nm, e = 0.5 (mmol/L)-1 cm-1 (20). Spectro-
photometric measurements were done in a double beam
Uvicon 940 spectrophotometer (Kontron Instruments)
equipped with a thermostatted cuvette compartment.
The GST-specific activity was expressed as enzymatic
units per grams of hemoglobin (units/gHb). To avoid any
hemoglobin interference with the absorbance of either
product we added in both sample and reference compart-
ments the same mixture containing 0.1 mol/L phosphate
buffer (pH 6.5) GSH (final concentration depending on
cosubstrate used) and an aliquot (5-10 AL) of the sample
(hemolysate). The reaction was started by the addition
of cosubstrate in the sample compartment and of an
equal volume of buffer or solvent in the reference
compartment. At least three independent measurements
were done for each sample with the two cosubstrates.
Glutathionylated Hb Mass Spectrometry Analysis.
Analyses of the glutathionylated hemoglobin were done
both on fresh and on singly frozen and thawed blood
samples. Matrix and sample were prepared for MALDI-
TOF MS by the sandwich layer method (21). Mass spectra
were analyzed using Bruker software Xtof. Glutathiony-
lated h hemoglobin quantified by MALDI-TOF was
calculated as a percentage of the total nonmodified h-
chain hemoglobin. The techniques followed for automat-
ic sample preparation, spotting on plate target, and
acquisition of spectra, have already been described (21).
Statistical Analyses. Statistical analyses were carried
out using the SPSS 15.0 (SPSS, Inc.) statistical package.
The frequencies of polymorphic genotypes and selected
characteristics of the subjects under study were deter-
mined using the Frequency procedure, whereas the
differences among groups were tested by the m2 test.
Continuous variables were described as mean F SD
and/or median, minimum, and maximum values as
determined using the Descriptives procedure. Because
the distributions of variables were highly skewed, we
analyzed the data employing two nonparametric tests,
i.e. the Mann-Whitney U test to compare two groups and
the Kruskal-Wallis H test to compare three groups. For
subjects with multiple measurements of airborne 1,3-
butadiene, statistical analyses were done using the
individual arithmetic mean values. Air or biological
levels that were below the limit of detection were
arbitrarily assigned a value of 0.5 of the detection limit
for the purpose of statistical analyses. The correlation
between variables was assessed using Spearman’s U. The
influence of age, smoking habit, alcohol consumption,
genetic polymorphism of GST, and residence on the
activity of GST enzymes and the percentage of gluta-
thionylated hemoglobin was evaluated by monovariate
analysis. Those variables influencing the investigated
biomarkers in the monovariate analysis were included in
a multiple regression model to evaluate the effects of
airborne 1,3-butadiene exposure (ln-transformed), work
job (0 = foresters, 1 = petrochemical workers), and GSTT1
genotype (0 = null genotype, 1 = active genotype), taken
as independent variables, on biomarker levels (ln-trans-
formed), taken as dependent variables. A P value of
<0.05 was considered significant.
Results
Selected characteristics of studied subjects divided
according to job title are reported in Table 1. A
comparison of the three groups shows the main differ-
ences to be: (a) 1,3-butadiene exposed workers were
younger than either workers not exposed to 1,3-butadi-
ene or foresters; (b) alcohol consumption was higher in
Effects of Low Doses 1,3-Butadiene Exposure on GST and Glutathionylated Hb
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foresters than in the other two groups; and (c) the
foresters lived in rural areas, whereas petrochemical
workers, either exposed to 1,3-butadiene or not, were
mainly resident in urban and suburban areas.
Effect of 1,3-Butadiene Exposure on GST Activity
and Glutathionylated Hemoglobin. Personal exposure
to 1,3-butadiene resulted significantly higher in 1,3-
butadiene-exposed workers than in workers not exposed
to 1,3-butadiene or in foresters. Marginally higher
airborne 1,3-butadiene levels were found when compar-
ing workers not exposed to 1,3-butadiene with foresters
(P = 0.075). GST activity was assayed with two different
substrates (EPNP and CDNB) with the aim of distin-
guishing between GST T1-1 and GST P1-1 isoenzymes
present in the RBC. There was a significant decrease of
GST activity in the RBC of both 1,3-butadiene-exposed
workers and in workers not exposed to 1,3-butadiene in
comparison with foresters. With EPNP as the cosub-
strate, the median values for 1,3-butadiene-exposed
workers and for workers not exposed to 1,3-butadiene
were 9.2 units/g Hb (range, 1.5-101.5) and 8.0 units/g
Hb (2.3-70.0) respectively; these levels were significantly
lower than the values of 59.0 units/g Hb (18.4-110.0)
observed in foresters. With CDNB as the cosubstrate, the
median values for 1,3-butadiene-exposed workers and
workers not exposed to 1,3-butadiene were 3.6 units/g
Hb (ranging from 1.2 to 8.8) and 3.2 units/g Hb (0.6-11.2),
respectively. Again, these values resulted significantly
lower than the 8.3 units/g Hb (2.5-26.6) found in the
forester group of subjects. In the case of glutathionylated
hemoglobin, we observed a significant increase in both
groups of petrochemical workers with median values of
6.6% (ranging from 3.6 to 17.1) in 1,3-butadiene-exposed
workers and 6.0% (2.8-9.9) in workers not exposed to 1,3-
butadiene, in comparison with 2.3% (<0.5-9.6) in the
Table 1. Comparison of age and other lifestyle characteristics in the various groups of subjects under study
Foresters Workers not
exposed to BD
BD-exposed
workers
P value for differences
among groups
No. subjects 82 43 42
Age, y* 41 (9) 42 (7) 34 (7) <0.001
c
Duration on the present job, y
b
8 (1-30) 7 (1-31) 7 (1-32) 0.108
c
Cigarette smoking
Smokers (%) 24 26 29 0.880x
No. cigarettes/d* 12 (6) 15 (8) 12 (5) 0.525
c
Alcohol consumption
Drinkers (%) 80 86 98 0.030x
g/wk* 334 (224) 159 (112) 194 (109) <0.001
c
Residence
Urban (%) 3 42 29 <0.001x
Suburban (%) 7 37 52
Rural (%) 90 21 19
Abbreviation: BD, 1,3-butadiene.
*Mean (SD).
cSignificance for comparison performed by the Kruskas-Wallis H test.
bMean (minimum-maximum).
xSignificance for comparison performed by the m2 test.
Table 2. Airborne BD levels, GST activities, and glutathionylated hemoglobin in the three groups of subjects
under study
Statistics Foresters Workers not
exposed to BD
BD-exposed
workers
P value for difference
among groups
Airborne BD (Ag/m3) Valid n 24 43 42 <0.001c
Mean (SD)* 0.3 (0.3) 0.9 (1.0) 11.5 (35.8)
Median (min-max) 0.1 (<0.1-1.0) 0.4 (<0.1-3.8) 1.5 (0.1-220.7)
GST activity with EPNP
(units/g Hb)
Valid n 79 41 37 <0.001
c
Mean (SD)* 60.2 (23.5) 21.9 (21.0) 24.2 (26.2)
Median (min-max) 59.0 (18.4-110.0) 8.0 (2.3-70.0) 9.2 (1.5-101.5)
GST activity with CDNB
(units/g Hb)
Valid n 79 33 37 <0.001
c
Mean (SD)* 8.6 (3.2) 3.5 (2.1) 3.9 (1.9)
Median (min-max) 8.3 (2.5-26.6) 3.2 (0.6-11.2) 3.6 (1.2-8.8)
Glutathionylated
hemoglobin (%)
Valid n 76 41 41 <0.001
c
Mean (SD)* 2.1 (1.7) 6.3 (2.0) 7.2 (2.8)
Median (min-max) 2.3 (<0.5-9.6) 6.0 (2.8-9.9) 6.6 (3.6-17.1)
* Std. Deviation.
cSignificance for comparison performed by the Kruskas-Wallis H test.
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forester control group. No significant difference was
found when the levels of GST activity, using either
EPNP and CDNB, and glutathionylated hemoglobin
were compared between workers not exposed to
1,3-butadiene and 1,3-butadiene-exposed workers. All
these data are summarized in Table 2 and shown in
Fig. 1.
Table 3 reports Spearman’s U correlation coefficients
between environmental and biological markers in all the
investigated subjects. A significant correlation was found
between all these parameters, with negative correlations
between personal exposure to 1,3-butadiene and GST
activity toward both the substrates, and positive correla-
tion between 1,3-butadiene personal exposure and
percentage of glutathionylated hemoglobin. An inverse
correlation was found between glutathionylated hemo-
globin and GST activities (Spearman’s U up to 0.567).
When subjects were divided according to working
settings, i.e., foresters versus petrochemical workers, high
correlation coefficients were found for all the parameters,
positive for 1,3-butadiene exposure and glutathionylated
hemoglobin and negative for GST activities.
Genetic Polymorphism of Glutathione Transferases.
The deletion of both GSTM1 (4) and GSTT1 (5) genes as
well as the distribution of allelic variants of GSTP1 (6)
has been studied in all three groups (Table 4). The
observed genotype frequencies are in agreement with
allele frequencies previously reported for other European
populations (7). No differences in the frequencies of
genotypes among the groups with different job titles
were found (the m2 test was used for such comparison).
Based on this observation, the total study group (N =
167) was used to analyze the effects of polymorphic
genotypes on biomarkers (Table 4). In the case of GST
enzymatic activity with EPNP, we observed significantly
higher levels in subjects bearing the GSTP1 BC genotype
(median, 76.1 units/g Hb; range, 26.1-104.6 units/g Hb)
than in the other genotypes subgroups (median range,
1.5-48.3 units/g Hb) and in subjects with the GSTT1
active genotype (median, 47.7 units/g Hb; range 2.3-
110.0 units/g Hb), in comparison with the null genotype
(median, 23.1 units/g Hb; range, 1.5-104.2 units/g Hb).
The effect of the GSTM1 genotype polymorphism on
the same enzymatic activity was not evaluated due to
the lack of GST M1-1 enzyme in the erythrocytes. No
difference in GST activity with CDNB was found for
the different GSTP1 genotypes, whereas the effect of
GSTT1 and GSTM1 was not evaluated due to the fact
that CDNB is not a substrate of GST T1-1 and again that
GST M1-1 is absent in the erythrocytes. No significant
influence of GST genetic polymorphisms was observed
for glutathionylated hemoglobin.
Multiple Linear Regression Analysis. The results of
the adjusted multiple regression analysis are reported in
Table 5. In the present model, airborne 1,3-butadiene
exposure (ln-transformed), GSTT1 genetic polymor-
phism, and work setting were introduced as independent
variables, whereas the GST activity toward both EPNP
and CDNB or the level of glutathionylated hemoglobin
(ln-transformed) were introduced as dependent varia-
bles. In an explorative phase, other variables such as age,
alcohol intake (no alcohol drinker = 0, alcohol drinker = 1),
cigarette smoking (no smoker = 0, smoker = 1), area of
Figure 1. Box plots of airborne 1,3-butadiene (A) and GST
activity with EPNP (B), CDNB (C), and glutathionylated
hemoglobin (D) in subjects divided according to job title. BD,
1,3-butadiene.
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residence (rural = 1, suburban = 2, urban = 3), and GSTP1
genetic polymorphism (wild type = 0, mutate = 1) were
tentatively introduced into a multiple linear regression
model, but none of them showed a significant influence
on the investigated bioindices and were excluded
therefore from the final analysis.
The final model was highly significant for all the
bioindices with R2adj ranging from 0.388 to 0.506.
However, no statistically significant influence of 1,3-
butadiene exposure was observed on either GST activity
or level of glutathionylated hemoglobin. On the contrary,
a strong effect of work setting (foresters = 0, petrochem-
ical workers = 1) was found on each biomarker; this
variable alone explained from 28.8% up to 43.9% of the
total observed variability. The significant effect of GSTT1
genetic polymorphism on GST activity toward EPNP,
already observed in the monovariate analysis, was
confirmed also in the multivariate analysis.
Discussion
The aim of this work was to study the effect of 1,3-
butadiene exposure on GST activity in workers
occupationally exposed to this toxic compound. Expo-
sure in 1,3-butadiene-exposed workers was low, with
median of 1.5 Ag/m3 and mean values of multiple
determination ranging from 0.1 to 220.7 Ag/m3. These
levels are well below the occupational limit value
recommended by the American Conference of Govern-
mental Industrial Hygienists of 2 ppm or 4,400 Ag/m3
as the time-weighted average threshold limit value
(22). The levels found in petrochemical workers not
exposed to 1,3-butadiene, ranging from undetectable to
3.8 Ag/m3, were in the same order of magnitude of
those of the general population exposed to 1,3-butadiene
as a component of urban pollution (10, 11), whereas
the exposure in foresters was even lower, as expected
among subjects working in a rural environment. A
high interindividual and intraindividual variability in
exposure to volatile chemicals is a common observation
in the chemical industry. Variability increases with
the levels of exposure, as observed also in this study
(Fig. 1).
GSTs are important enzymes of detoxification that
are also involved in the inactivation of oxidative
metabolites of 1,3-butadiene (2) and of other chemicals,
and an increased expression with a concomitant
increase of enzymatic activity would be expected in
response to exposure. Our data (Fig. 1; Table 2) suggest
the opposite: the RBC of workers exposed to low doses
of 1,3-butadiene contain a significantly lower GST
Table 3. Spearman R for correlations between airborne BD, biomarkers of oxidative stress, and work setting
(foresters = 0, petrochemical workers = 1)
GST activity
with EPNP
GST activity
with CDNB
Glutathionylated
hemoglobin
Work setting
Airborne BD, (Ag/m3) 0.230* (102) 0.299c (94) 409c (104) 0.424c (109)
GST activity with EPNP, (units/g Hb) 0.507
c
(145) 0.477c (151) 0.629c (157)
GST activity with CDNB (units/g Hb) 0.567c (143) 0.732c (149)
Glutathionylated hemoglobin (%) 0.802
c
(158)
*P < 0.05.
cP < 0.01, the number of pairs in parentheses.
Table 4. Effect of genotype on biomarkers of oxidative stress in all the investigated subjects
Genotype Genotype
subgroups, n
GST activity with EPNP
(units/g Hb)
GST activity with CDNB
(units/g Hb)
Glutathionylated
hemoglobin (%)
Median (min-max) Median (min-max) Median (min-max)
GSTP1 AA, 79 43.1 (2.3-103.8) 5.6 (0.6-14.5) 4.7 (0.5-13.1)
AB, 59 48.3 (2.3-110.0) 6.8 (1.3-26.6) 3.5 (0.5-17.1)
AD, 1 47.7 1.9 4.4
BC, 8 76.1 (26.1-104.6) 6.4 (3.3-8.3) 2.6 (0.5-7.7)
AC/BD, 13 37.5 (2.3-75.5) 6.1 (1.7-10.2) 3.6 (0.5-9.9)
BB, 4 20.4 (3.1-25.5) 4.6 (2.2-11.2) 5.5 (3.2-8.7)
CC, 1 1.5 6.7 4.7
P* 0.027 0.800 0.742
GSTT1 Positive, 122 47.7 (2.3-110.0) N.E.
c
4.4 (0.5-13.1)
Null, 43 23.1 (1.5-104.2) 3.5 (0.5-17.1)
P
b
0.001 — 0.097
GSTM1 Positive, 79 N.E.x N.E.x 3.7 (0.5-12.6)
Null, 86 4.4 (0.5-17.1)
P
b
— — 0.553
Abbreviation: N.E., not evaluated.
* Significance for comparison performed by the Kruskas Wallis test.
cNot evaluated because CDNB is not a substrate for GSTT1 .
bSignificance for comparison performed by the Mann-Whitney U test.
xNot evaluated because GSTM1 is absent in the erythrocytes.
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enzymatic activity despite the biological variation in
individual GST levels being quite large. A wide
variation in the levels of GST activity was found in
two different laboratories (23, 24), suggesting that these
considerable interindividual differences may be due
either to the presence of postsynthetic modifications or
to the expression of highly inducible genes. The
distribution of different GST classes inside the eryth-
rocytes is well known (25, 26). The predominant form is
the GST P1-1 enzyme, originally purified from human
placenta, followed by the GST T1-1 present in minor
amounts (27, 28); other classes, if present, are barely
detectable. GST P1-1 has been reported to lose
enzymatic activity after exposure to oxidant agents
(29), alkaline pH (30), and metals (31), and it has been
suggested that this enzyme from human erythrocytes
could be a possible marker of chemical exposure (32)
and may exist also in monomeric and posttranslation-
ally modified forms (33). We have therefore tested the
hypothesis that exposure to low doses of 1,3-butadiene
may induce oxidative stress inside the RBC with
parallel loss of GST P1-1 activity and, therefore, we
further analyzed the RBC of the above three groups for
their content of Glutathionylated Hemoglobin (GSS-Hb)
(a possible index of oxidative stress) by MALDI-TOF
spectra (21). A significant increase of GSS-Hb was found
in both the 1,3-butadiene-exposed workers and the
workers not exposed to 1,3-butadiene, in comparison
with the foresters group (Fig. 1; Table 2). The statistical
analysis (Table 3) indicated that a weak but still
significant negative correlation was found between 1,3-
butadiene exposure level and GST activity, whereas a
positive correlation was found between 1,3-butadiene
exposure and GSS-Hb values. Strong negative correla-
tions were also found between GST activities and GSS-Hb
levels (Spearman’s q of 0.477 and 0.567 when tested
with EPNP and CDNB, respectively). Therefore, our
study associates GSS-Hb levels with changes in GST
activity of the RBC and suggest that the oxidative stress
may influence them in an opposite way, that is, increasing
the GSS-Hb levels and decreasing the GST activity. We
should note, however, that these results (in terms of loss
of GST activity and increase of GSS-Hb levels) are similar
to those found in the group of workers not exposed to
1,3-butadiene (Table 1), where 1,3-butadiene exposure
(0.85 F 0.16 Ag/m3) was much lower than that of 1,3-
butadiene-exposed workers (6.44 F 2.17 Ag/m3). There-
fore, we should conclude that other factors, such as
chemical compounds different from 1,3-butadiene and
present in different areas of the chemical plant (industry),
may be also responsible for inducing oxidative stress; so
that the work setting (petrochemical plant versus forest)
may be of greater importance in explaining both the GST
activity and GSS-Hb (Tables 3 and 5) than 1,3-butadiene
exposure itself.
No data on the behavior of GSS-Hb following
environmental or occupational exposure to chemicals,
as far as we know, has been reported to date. Similarly,
no evaluation of the influence of genetic polymorphism
of GST or personal habit (i.e., cigarette smoking) on this
recently introduced biomarker has been done to our
knowledge. On the other hand, a number of studies have
been recently done to evaluate the levels of GSS-Hb in
diseases in which an oxidative stress is believed to play a
role (34, 35). Our data, for the first time, show that
exposure to chemicals may also modify this biological
index in agreement with similar modifications observed
following a condition of oxidative stress.
A statistical analysis has also been carried out to
further evaluate whether any of the selected character-
istics of the subjects could affect the investigated
biomarkers. Age, alcohol consumption, cigarette smok-
ing habits, and area of residence were all considered. An
influence of smoking habits on GST activity was
anticipated as many of the compounds found in cigarette
smoke are electrophilic and oxidants, among them
oxygen radical species and hydrogen peroxide (36)
whose detoxification is mediated by conjugation with
glutathione catalyzed by GST. Similarly, ethanol can also
exert an oxidative stress on GST enzymes, as shown in
primary culture of mouse hepatocytes (37). Interestingly,
though, statistical analysis of our data showed no
significant effect of potential confounders such as
smoking habits, alcohol intake, age, or area of residence
on GST activity and GSS-Hb levels.
The distribution of genetic polymorphism of GSTs
(GSTM1 or GSTT1 deletion or GSTP1 allelic variants)
among the three groups is similar (data not shown) and
cannot explain the differences in the levels of bio-
markers found here between petrochemical workers and
Table 5. Evaluation of airborne BD exposure, occupational setting, and GSTT1 genotype on GST activity of and
glutathionylated hemoglobin according to a multiple regression analysis: ln (biomarker) = constant + ln (Airborne
BD)  b1 + work setting  b2 + GSTT1  b3
GST activity with EPNP
(units/g Hb)
GST activity with CDNB
(units/g Hb)
Glutathionylated
hemoglobin (%)
b Rp
2 b Rp
2 b Rp
2
Constant 3.301* — 2.296* — 0.602* —
Airborne BD 0.027 0.002 0.029 0.009 0.033 0.012
Work setting 1.497* 0.288 0.958* 0.391 1.139* 0.439
GSTT1 0.980* 0.182 0.229c 0.045 0.141 0.016
Whole model R2 adj 0.388 0.419 0.506
Whole model P <0.001 <0.001 <0.001
NOTE: Values of constant, b -coefficients, and partial R2 (Rp
2) for each term of the equation are given. Adjusted Radj
2 and significance for the whole model
are reported in the last two rows.
* Significant at P < 0.01.
cSignificant at P < 0.05.
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foresters. However, when the effect of the GSTP1
polymorphic variants on GST enzymatic activity with
EPNP was evaluated (Table 4), the activity was higher in
individuals possessing the GSTP1BC genotype in
comparison with that of the other genotype subgroups
(Table 4), and the difference was statistically significant.
These results are consistent with previous reports
suggesting that the enzymatic activity can be influenced
by the distribution of GSTP1 polymorphic variants (3),
but it is also highly substrate-dependent (19). As
expected, the individuals bearing the GSTT1 gene
showed a higher enzymatic activity in comparison with
individuals with null genotype (Table 4). The residual
activity measured in the subgroup lacking the GSTT1
gene can be explained by the fact that EPNP is also a
substrate of GST P1-1.
The results of the multiple regression model, with
coefficients of determinations (adjusted) up to 0.506
(Table 5), substantially confirmed what was observed in
the monovariate analysis, and showed that the biggest
contribution to the variability of the biomarkers under
study was the work setting, followed by the GSTT1
genotype; whereas the contribution of individual 1,3-
butadiene exposure was not significant.
In conclusion, the results of this study showed that
occupational exposure to low doses of 1,3-butadiene and
probably also to other chemicals may indeed induce
oxidative stress and impair the GST balance in the RBC
of workers and, therefore, suggest that the measurement
of GST activity and of the GSS-Hb levels can be
recommended as promising biomarkers of effect in
petrochemical workers.
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